INDIANA UNIVERSITY AND PHARMATROPHIX PRESENT FINDINGS ON PERFORMANCE OF ORAL THERAPEUTIC, LM11A-31, TO REDUCE DECLINE OF BRAIN FUNCTIONAL-NETWORK CONNECTIVITY IN ALZHEIMER'S DISEASE
New findings presented at featured research session (FRS) during the Alzheimer's Association International Conference demonstrate statistically significant slowing of decline in brain network function with LM11A-31 vs placebo linked to cognitive domains and synaptic resilience MENLO PARK,...
New findings presented at featured research session (FRS) during the Alzheimer's Association International Conference demonstrate statistically significant slowing of decline in brain network function with LM11A-31 vs placebo linked to cognitive domains and synaptic resilience MENLO PARK,...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.